Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion evidence source_evidence_literature NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion SIO_000772 22781708 NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion wasDerivedFrom befree-20150227 NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion wasGeneratedBy ECO_0000203 NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.